Parkinson’s UK calls on government to mark World Patient Safety Day
PharmaTimes
SEPTEMBER 21, 2023
The report outlines ways the government can help patients with Parkinson’s disease - News - PharmaTimes
Novo Nordisk's obesity drug Wegovy to be provided to more patients under UK pilot program
Fierce Pharma
JUNE 7, 2023
The rush to provide revolutionary weight-loss drugs to obese patients has reached the U.K. | The rush to provide revolutionary weight-loss drugs to obese patients has reached the U.K.
Patients 
264
264 Join 8,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
US appeal in high-stakes Gilead patent case garners support from patient advocates
Fierce Pharma
MAY 31, 2023
government in a high-stakes HIV patent case, patient advocates are backing the U.S.’ government in a high-stakes HIV patent case, patient advocates are backing the U.S.’ Weeks after Gilead Sciences prevailed over the U.S. push to appeal. | Weeks after Gilead Sciences prevailed over the U.S. push to appeal.
Patients 187
187 
Moderna and UK government sign deal to establish mRNA facility
Pharmaceutical Technology
DECEMBER 21, 2022
Moderna and the UK government have entered a ten-year strategic collaboration to build a messenger ribonucleic acid (mRNA) research, development and manufacturing facility in the country. The post Moderna and UK government sign deal to establish mRNA facility appeared first on Pharmaceutical Technology.
Government 140
140 
Pharma responds to UK government Statutory Scheme rise
European Pharmaceutical Review
MARCH 3, 2023
The UK government has confirmed its plans to go ahead with the intended Statutory Scheme rate rise. Through the schemes, the government intends that medicines are supplied at an affordable price both in the life sciences sector and the broader economy. percent to 27.5 billion in associated tax revenues up to 2058.
Government 84
84 
National cancer group reports widespread chemo shortages, calls on government and industry to help resolve them
Fierce Pharma
JUNE 7, 2023
As pharma supply chain problems drag on, a shortage of key cancer drugs has afflicted a large number of treatment centers and many patients. | The National Comprehensive Cancer Network's recent survey shows that nearly all of the treatment centers it polled are facing a carboplatin shortage.
Government 261
261 
UK Government to fund research into new obesity treatments
Pharmaceutical Technology
NOVEMBER 28, 2022
The UK Government has announced funds worth $24.17m (£20m) to conduct research for developing new obesity therapies and technologies. The latest investment by the government is anticipated to aid the NHS in saving billions over time and guarantee that crucial funds are allocated to important key frontline services.
Government 90
90 
Europe names hundreds of critical medicines in quest to counter drug shortages
Fierce Pharma
DECEMBER 12, 2023
Over the past several years, drug shortages have vexed doctors and patients on both sides of the Atlantic, prompting lawmakers and government agencies to take action in both Europe and the U.S. Tuesday, the European Medicines Agency laid out a list of more than 300 critical generic drugs that could fall prey to future shortages.
Medicine 355
355 
Governments and pharma relationships and implications for antimicrobial resistance
Pharmaceutical Technology
AUGUST 1, 2022
Before the Covid-19 pandemic, government-led investment and engagement in life sciences was relatively restricted worldwide, with the industry mostly funded via private investment. The pandemic forced governments to acknowledge that this status quo had to change.
Government 93
93 
Global comparator data signal “alarm bells” for UK Government, says APBI
pharmaphorum
JULY 27, 2022
Latest UK Life Sciences Competitive Indicators “ought to ring alarm bells across Government,” says ABPI. Richard Torbett, chief executive at the Association of the British Pharmaceutical Industry (ABPI) said Life Sciences Competitive Indicators (LSCI) data published last week “ought to ring alarm bells across Government”.
Government 88
88 
UK government launches pathway for innovative technologies
PharmaTimes
SEPTEMBER 22, 2023
IDAP aims to address unmet clinical needs for patients and healthcare professionals - News - PharmaTimes
Government 98
98 
Novel Approaches Are Essential for Enabling Patient-First Outcomes in Value Based Care Models
MedCity News
JANUARY 25, 2024
health outcomes while reducing healthcare spending, I am heartened by the exciting ways in which government organizations and the private sector are innovating and deploying new technologies that can achieve these goals. Despite the significant challenges to improving U.S.
Government 111
111 
Government issues final rules to prevent surprise medical bills
MedCity News
AUGUST 24, 2022
Following litigation battles and multiple iterations of the Act, the final rules address the arbitration process for insurers and provide more transparency for patients.
Government 98
98 
Transforming Patient Centricity to Patient Inclusive within Medical Affairs
PM360
JUNE 11, 2022
What is the value of a patient-centric approach if that approach doesn’t include the patients themselves? They want a patient inclusive approach. More specifically, what role is Medical Affairs playing in working with patients to create educational materials that would make sense to fellow patients?
Patients 98
98 
Answering 7 Key Questions About Change Healthcare’s Cyberattack
MedCity News
MARCH 7, 2024
The aftermath the cyberattack on Change Healthcare remains messy, with patients across the country still struggling to obtain their prescriptions. The federal government has even stepped in to help address the fallout of the attack, urging payers to quickly alleviate the digital bottlenecks that providers and pharmacies are facing.
Prescription 126
126 
ViiV, Roche and Pfizer top in ESG, according to patients
European Pharmaceutical Review
JULY 12, 2022
According to a recent survey of patient groups, Roche, Pfizer, ViiV Healthcare and Gilead Sciences are among the top companies for implementing and reporting progress on environmental, social, governance (ESG) activities.
Patients 99
99 
BioNTech forms cancer immunotherapies partnership with UK Government
PharmaTimes
JANUARY 6, 2023
Collaboration will focus on providing up to 10,000 patients with personalised mRNA by 2030
Government 85
85 
Signal: Allina health will no longer bar indebted patients from care
Pharmaceutical Technology
AUGUST 27, 2023
Following public outcry and a government investigation, Allina Health has reneged on their policy barring debtors from out-patient care.
Patients 52
52 
Revolutionizing Rare Disease Research: Unleashing the Power of Patient Advocacy and Artificial Intelligence
PM360
MARCH 22, 2024
Exploring the role of patient advocacy groups and clinical trials while discussing the challenges faced, and how artificial intelligence and modern methods revolutionize the landscape. As a result, newly diagnosed families frequently rely on patient advocacy groups (PAGs) for up-to-date information.
Patients 52
52 
Steps to building a more patient-centric industry
pharmaphorum
DECEMBER 1, 2022
Lack of access, strict regulations, and demanding schedules have made it extremely difficult for patients to participate in clinical trials. A 2018 NIH survey found that patients felt clinical trial participation to be inconvenient and burdensome, and nearly half (49.0%) said it disrupted their daily routine.
Patients 102
102 
Outsourcing APIs put EU patients at risk
European Pharmaceutical Review
OCTOBER 28, 2022
A new report , Addressing Europe’s Medicine Exodus by Teva called on legislators to ensure a safer, more secure supply of essential medicines for EU patients, by cutting reliance on low-cost markets. The research showed 10 percent of EU patients with chronic diseases suffered shortages of essential medicines during the Covid-19 pandemic.
Patients 88
88 
As pharma abandons the antibiotic market patients are at risk
World of DTC Marketing
MARCH 3, 2021
A push could be the government(s) paying pharma to develop new antibiotics or paying for their patent. The post As pharma abandons the antibiotic market patients are at risk appeared first on World of DTC Marketing.com. My guess is a mixture of both push and pull is needed.
Pharma 174
174 
Putting Patients First: Improving the Pharmaceutical Supply Chain
Impetus Digital
JANUARY 30, 2023
Medications and supplies must be handled with the utmost care, often needing to comply with strict temperature regulations and changing demands from patients and providers that vary depending on the country. Add this to infrastructure challenges like cold storage or delays, and it’s no wonder patient needs are not always put first.
Most Hospitals Are Still Violating HIPAA By Using Web Tracking Tools, Despite Federal Warnings
MedCity News
SEPTEMBER 15, 2023
The federal government has warned hospitals that using third-party analytics tools on their websites could violate HIPAA, and more than 20 hospitals are facing class-action lawsuits over the use of these tools. But a recent analysis found that hospitals are doing a poor job of fixing their websites and preventing patient data collection.
Government 126
126 
How to Modernize Clinical Trials to Promote Enhanced Patient Diversity and Access
PM360
JULY 26, 2023
An initial and discernible benefit to adopting decentralized clinical trial (DCT) models is alleviating patient burden by mitigating unnecessary travel through the utilization of eClinical platforms, mobile phlebotomy/nursing services, local clinics, and other technologies.
Patients 95
95 
Specialty pharma’s next big opportunity: it’s time for patient access to adopt an open protocol
pharmaphorum
NOVEMBER 1, 2022
a power Visa and ultimately the government could not deny. Along their journey, specialty pharma patients interact with a series of siloed institutions: clinics, specialty pharmacies, copay program vendors, patient assistance programs, nurses, etc. to make the patient experience as seamless as possible.
Patients 96
96 
Patient centricity and the changing pharmaceutical vista
pharmaphorum
JANUARY 27, 2023
Having previously spoken with Dr Mullen three years ago when she was country medical director for the UK & Ireland at GSK – on the topic of patient centricity and embedding that focus within the core of a pharmaceutical company – our recent interview provided some interesting insights into the changing landscape of the industry.
Patients 92
92 
US Prescription Drug Costs More Than Double Those in Canada [Sponsored]
MedCity News
SEPTEMBER 4, 2023
Increasingly, patients in the U.S. look to Canada for more affordable prescription options since the Canadian government regulates drug costs. Some companies have noticed and are beginning to capitalize on the demand.
Prescription 107
107 
Report: Firearm-related Injuries Cost US Healthcare $1B Annually
MedCity News
APRIL 25, 2023
healthcare system $290 million, or about $6,400 per patient, according to a report from the Commonwealth Fund. These costs are mostly covered by Medicaid and other government insurance programs. In just 2020, deaths from gun violence cost the U.S.
Healthcare 131
131 
Generative AI’s potential to speed delivery of improved patient outcomes
Clarivate
JUNE 29, 2023
We’re mindful of some challenges that life science and healthcare organizations must work through before this technology is mature enough for use in critical business decisions that may impact patient health. Our customers entrust our products and services to help them improve patient health, and we will not jeopardize that mission.
Patients 98
98 
How the US’s pending PIE Act will improve patient access to medication
pharmaphorum
JUNE 27, 2022
Jennifer Mathieu, director of government relations at the Academy of Managed Care Pharmacy (AMCP), tells us why the organisation backed the pre-approval information exchange (PIE) Act of 2022 and how the legislation will empower companies to share information with healthcare payers and plans during the FDA approval process. .
Reaching Crucial Hispanic Patient Audiences
PM360
SEPTEMBER 28, 2022
One fast-growing group in particular that requires a patient-centric and culturally relevant approach to marketing is the Hispanic audience, which is extremely diverse. The patient landscape continues to evolve. A study of Hispanic patients’ U.S. Evolving Demographics. Ethnic and/or racial groups comprise 100% of U.S.
Patients 98
98 
The drug industry can’t fight change
World of DTC Marketing
SEPTEMBER 7, 2021
Industry lobbyists claim that any government attempt to intervene in pharmaceutical companies’ price-setting would stifle innovation and prolong the fight against Covid-19. Recent research has also found that the policy change could save individual patients thousands of dollars on crucial prescription medications.
Government 209
209 
Data integrity considerations in Pharma and Life Sciences
European Pharmaceutical Review
MARCH 12, 2024
Life science companies are increasingly using advanced technologies like artificial intelligence (AI), machine learning (ML) and blockchain to improve data quality and integrity by detecting anomalies in data and establishing tamper-proof audit trails for all data-related activities Data governance. What is an effective solution?
Government 90
90 
No Surprises Act Leads to Thousands More Disputes and Delays than Gov’t Expected
MedCity News
NOVEMBER 21, 2022
When the federal government enacted the No Surprises Act to lessen payment disputes between a patient or a health insurance plan and a provider, the government projected 22,000 disputes in 2022. However, between just April and September there were more than 90,000 disputes filed. .
Leads 98
98 
Pharma, patient advocates clash over Inflation Reduction Act
Pharmaceutical Technology
MAY 17, 2023
Merith Basey, the executive director of the advocacy group Patients for Affordable Drugs, said that CMS’s lack of negotiating power is a key reason that US patients pay up to four times as much for drugs as patients in other countries.
How one pharma “family business” places patients first
pharmaphorum
OCTOBER 26, 2022
And just as a family business thrives on its connection to the community, Chiesi is committed to connecting to the global patient community. We try to have a very long-term orientation because we believe that aligns our objectives very well with the objectives of society and the patients we serve, and it makes us a stable business.”.
Patients 73
73 
How Hospitals Can Help Prevent Medical Debt
MedCity News
JULY 13, 2023
Local governments around the country are using Covid relief funds to eliminate medical debt for their communities. Provide training to your teams on how to communicate with patients to make it clear that financial assistance is available and encourage those who may qualify to apply. But Covid relief funds are not a long-term solution.
Medical 96
96 
Data-Driven Connections: Linking Rare Disease Patients to Clinical Trials, Experts, and Resources
PM360
JUNE 16, 2023
Simply put, identifying a disorder and receiving a formal diagnosis is at the root of myriad difficulties—from connecting a patient to a community to generating an appropriate care and treatment plan that ideally goes beyond managing symptoms to connecting a patient to clinical trials.
Patients 52
52 
To Combat Illness in LGBTQ+ Communities, Health Groups Must Tap Into ‘Chosen Circles’
MedCity News
DECEMBER 29, 2023
It’s time to transform how government health agencies, pharmaceutical companies, hospitals and other health organizations create and deliver information to the approximately 20 million members of LGBTQ+ communities. Start with paying attention to their “chosen circles” or their trusted sources of information.
Government 111
111 
The hypocrisy of big pharma
World of DTC Marketing
SEPTEMBER 23, 2021
The suggestion by Pfizer’s CEO that drug pricing negotiations with the government would slow innovation is PR doubletalk. To me, this says that the approval of the drug WAS about money, not patients. trillion social spending package. Remember when J&J asked for help from Pfizer on their vaccine?
Pharma 214
214 
What are the Benefits of Patient Portals?
Referral MD
MARCH 28, 2022
One of the latest iterations of our digitization comes in the form of the patient portal, an online hub designed to keep healthcare consumers in the treatment loop. Like the EHR, patient portals have been mandated by federal regulatory guidelines. What Are the Benefits of Patient Portals? Why are patient portals beneficial?
Patients 59
59 
Five ways health systems are improving the patient experience
Clarivate
JULY 28, 2022
As a preview to the Clarivate Healthcare Business Insights 2022 Member Retreats coming this fall , we share how health systems are adapting their patient and staff experiences. If patients are unhappy, staff will bear the brunt of complaints and concerns. Allowing for real-time patient feedback.
Patients 52
52 
Pharmaceutical Procurement System Reform
Contrarian Sales Techniques
MARCH 3, 2023
The situation has led to concerns about the supply of essential medicines to patients and has sparked calls for pharmaceutical procurement reform. To summarize: The article discusses the situation with Pharmaniaga and its impact on the supply of essential medicines to patients in Malaysia.
Let's personalize your content